Adults: pms-GABAPENTIN (gabapentin) is indicated as adjunctive therapy for the management of patients with epilepsy who are not satisfactorily controlled by conventional therapy.
Geriatrics (> 65 years of age): Systematic studies in geriatric patients have not been conducted (see Use in the Elderly (>65 years of age) under PRECAUTIONS).
Pediatrics (< 18 years of age): The safety and efficacy in patients under the age of 18 have not been established (see Use in Children (<18 years of age) under PRECAUTIONS).